Floatz logo

Anakinra

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

M.D. Anderson Cancer Centerprotein_peptidePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

271 Active assets in the Diffuse Large B-Cell Lymphoma, Not Otherwise Specified cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
National Cancer Institute (NCI)
Phase 2/3A
Evomela
Ruijin Hospital
Phase 4BBB
Axicabtagene Ciloleucel
Ruijin Hospital
Phase 4BBB
PREDNISONE TABLETS
Beth Israel Deaconess Medical Center
Phase 4BBB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 3BBB

View all 50 →

Same molecule, other indications

Anakinra is also rated in:

obesity disorderDormant
BB
Indicative ·
64 / 100
View asset →
hypogonadotropic hypogonadismDormant
BB
Indicative ·
64 / 100
View asset →
adrenal gland hyperfunctionDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →